Search

Your search keyword '"Giorgini, A"' showing total 422 results
Start Over Author "Giorgini, A" Publisher elsevier b.v.
422 results on '"Giorgini, A"'

12. Uterine leiomyoma as useful model to unveil morphometric and macromolecular collagen state and impairment in fibrotic diseases: An ex-vivo human study

Author

Belloni, Alessia, Furlani, Michele, Greco, Stefania, Notarstefano, Valentina, Pro, Chiara, Randazzo, Basilio, Pellegrino, Pamela, Zannotti, Alessandro, Carpini, Giovanni Delli, Ciavattini, Andrea, Di Lillo, Francesca, Giorgini, Elisabetta, Giuliani, Alessandra, Cinti, Saverio, and Ciarmela, Pasquapina

Published
2022
Full Text
View/download PDF

13. Conventional feed additives or red claw crayfish meal and dried microbial biomass as feed supplement in fish meal-free diets for rainbow trout (Oncorhynchus mykiss): Possible ameliorative effects on growth and gut health status

Author

Zarantoniello, Matteo, Pulido Rodriguez, Lina Fernanda, Randazzo, Basilio, Cardinaletti, Gloriana, Giorgini, Elisabetta, Belloni, Alessia, Secci, Giulia, Faccenda, Filippo, Pulcini, Domitilla, Parisi, Giuliana, Capoccioni, Fabrizio, Tibaldi, Emilio, and Olivotto, Ike

Published
2022
Full Text
View/download PDF

25. Black Soldier Fly (Hermetia illucens) reared on roasted coffee by-product and Schizochytrium sp. as a sustainable terrestrial ingredient for aquafeeds production

Author

Zarantoniello, Matteo, Zimbelli, Andrea, Randazzo, Basilio, Compagni, Martina Delli, Truzzi, Cristina, Antonucci, Matteo, Riolo, Paola, Loreto, Nino, Osimani, Andrea, Milanović, Vesna, Giorgini, Elisabetta, Cardinaletti, Gloriana, Tulli, Francesca, Cipriani, Renato, Gioacchini, Giorgia, and Olivotto, Ike

Published
2020
Full Text
View/download PDF

26. Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

Author

Degasperi, Elisabetta, Spinetti, Angiola, Lombardi, Andrea, Landonio, Simona, Rossi, Maria Cristina, Pasulo, Luisa, Pozzoni, Pietro, Giorgini, Alessia, Fabris, Paolo, Romano, Antonietta, Lomonaco, Lorenzo, Puoti, Massimo, Vinci, Maria, Gatti, Federico, Carolo, Giada, Zoncada, Alessia, Bonfanti, Paolo, Russo, Francesco Paolo, Aghemo, Alessio, Soria, Alessandro, Centenaro, Riccardo, Maggiolo, Franco, Rovere, Pierangelo, Pasin, Francesca, Paon, Veronica, Faggiano, Giovanni, Vario, Alessandro, Grossi, Glenda, Soffredini, Roberta, Carriero, Canio, Paolucci, Stefania, Noventa, Franco, Alberti, Alfredo, Lampertico, Pietro, and Fagiuoli, Stefano

Published
2019
Full Text
View/download PDF

32. Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

Author

D'Ambrosio, Roberta, Pasulo, Luisa, Puoti, Massimo, Vinci, Maria, Schiavini, Monica, Lazzaroni, Sergio, Soria, Alessandro, Gatti, Federico, Menzaghi, Barbara, Aghemo, Alessio, Capelli, Francesca, Rumi, Maria Grazia, Morini, Lorenzo, Giorgini, Alessia, Pigozzi, Marie Graciella, Rossini, Angelo, Maggiolo, Franco, Pan, Angelo, Memoli, Massimo, Spinelli, Ombretta, Del Poggio, Paolo, Saladino, Valeria, Spinetti, Angiola, De Bona, Anna, Capretti, Andrea, Uberti-Foppa, Caterina, Bonfanti, Paolo, Terreni, Natalia, Menozzi, Fernanda, Colombo, Alberto Eraldo, Giglio, Omar, Centenaro, Riccardo, Borghi, Marta, Baiguera, Chiara, Picciotto, Viviana, Landonio, Simona, Gori, Andrea, Magnani, Carlo, Noventa, Franco, Paolucci, Stefania, Lampertico, Pietro, and Fagiuoli, Stefano

Published
2019
Full Text
View/download PDF

41. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

Author

Craxì, A., Petta, S., Calvaruso, V., Brunetto, M., Coco, B., Chessa, L., Pasetto, M.C., Bigliotti, E., Tamburrini, F., Montalto, G., Capitano, A.R., Ieluzzi, D., Fattovich, G., Zignego, A.L., Monti, M., Gragnani, L., Zuin, M., Finati, E., Giorgini, A., Angarano, G., Milella, M., Alessandro, F., Dallio, M., Mazzella, G., Lazzarini, G., Di Fine, M., Russo, F.P., Zanetto, A., Castelli, F., Zaltron, S., Raimondo, G., Filomia, R., Puoti, M., Danieli, E., Strazzabosco, M., Gemma, M., Angelico, M., De Leonardis, F., Gori, A., Cappelletti, E., Bruno, R., Cima, S., Coppola, C., Amoruso, D.C., Andreone, P., Simonetti, G., Gaeta, G.B., Brancaccio, G., Toniutto, P., Dissegna, D., Mondelli, M., Ludovisi, S., Persico, M., Masarone, M., Torti, C., Strazzulla, A., Rosina, F., Framarin, L., Weimer, L.E., Quaranta, M.G., Falzano, L., Mallano, A., Karampatou, Aimilia, Han, Xue, Kondili, Loreta A., Taliani, Gloria, Ciancio, Alessia, Morisco, Filomena, Critelli, Rosina Maria, Baraldi, Enrica, Bernabucci, Veronica, Troshina, Giulia, Guarino, Maria, Tagliavini, Simonetta, D'Ambrosio, Federica, Bristot, Laura, Turco, Laura, Rosato, Stefano, Vella, Stefano, Trenti, Tommaso, Neri, Isabella, La Marca, Antonio, Manthena, Shivaji, Goldstein, Andrea S., Bruno, Savino, Bao, Yanjun, Gonzalez, Yuri Sanchez, and Villa, Erica

Published
2018
Full Text
View/download PDF

46. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

Author

Loreta A. Kondili, Maria Giovanna Quaranta, Luisa Cavalletto, Vincenza Calvaruso, Luigina Ferrigno, Roberta D'Ambrosio, Ilaria Simonelli, Giuseppina Brancaccio, Giovanni Raimondo, Maurizia R. Brunetto, Anna Linda Zignego, Carmine Coppola, Andrea Iannone, Elisa Biliotti, Gabriella Verucchi, Marco Massari, Anna Licata, Francesco Barbaro, Marcello Persico, Francesco Paolo Russo, Filomena Morisco, Maurizio Pompili, Mauro Viganò, Massimo Puoti, Teresa Santantonio, Erica Villa, Antonio Craxì, Liliana Chemello, Valentina Panetta, Giovanni Battista Gaeta, Roberto Filomia, Barbara Coco, Monica Monti, Daniela Caterina Amoruso, Salvatore Madonia, Donatella Ieluzzi, Gloria Taliani, Lorenzo Badia, Guglielmo Marco Migliorino, Alessia Giorgini, Mario Masarone, Pierluigi Blanc, Valentina Cossiga, Martina De Siena, Xhimi Tata, Maria Grazia Rumi, Luchino Chessa, Pietro Lampertico, Carlo Ferrari, Ivan Gentile, Giustino Parruti, Leonardo Baiocchi, Alessia Ciancio, Pietro Invernizzi, Alessandro Federico, Carlo Torti, Giulia Morsica, Pietro Andreone, Alessio Aghemo, Patrizia Popoli, Stefano Vella, Kondili, L. A., Quaranta, M. G., Cavalletto, L., Calvaruso, V., Ferrigno, L., D'Ambrosio, R., Simonelli, I., Brancaccio, G., Raimondo, G., Brunetto, M. R., Zignego, A. L., Coppola, C., Iannone, A., Biliotti, E., Verucchi, G., Massari, M., Licata, A., Barbaro, F., Persico, M., Russo, F. P., Morisco, F., Pompili, M., Vigano, M., Puoti, M., Santantonio, T., Villa, E., Craxi, A., Chemello, L., Panetta, V., Gaeta, G. B., Filomia, R., Coco, B., Monti, M., Amoruso, D. C., Madonia, S., Ieluzzi, D., Taliani, G., Badia, L., Migliorino, G. M., Giorgini, A., Masarone, M., Blanc, P., Cossiga, V., De Siena, M., Tata, X., Rumi, M. G., Chessa, L., Lampertico, P., Ferrari, C., Gentile, I., Parruti, G., Baiocchi, L., Ciancio, A., Invernizzi, P., Federico, A., Torti, C., Morsica, G., Andreone, P., Aghemo, A., Popoli, P., Vella, S., Kondili, Loreta A, Quaranta, Maria Giovanna, Cavalletto, Luisa, Calvaruso, Vincenza, Ferrigno, Luigina, D'Ambrosio, Roberta, Simonelli, Ilaria, Brancaccio, Giuseppina, Raimondo, Giovanni, Brunetto, Maurizia R, Zignego, Anna Linda, Coppola, Carmine, Iannone, Andrea, Biliotti, Elisa, Verucchi, Gabriella, Massari, Marco, Licata, Anna, Barbaro, Francesco, Persico, Marcello, Russo, Francesco Paolo, Morisco, Filomena, Pompili, Maurizio, Viganò, Mauro, Puoti, Massimo, Santantonio, Teresa, Villa, Erica, Craxì, Antonio, and Chemello, Liliana

Subjects
Settore MED/12, Real-life cohort, Hepatology, Direct-acting antiviral, HCC, Long term outcomes, Predictive factors, Gastroenterology, Long term outcome, Predictive factor
Abstract

Background and aims: Severe liver disease markers assessed before HCV eradication are acknowledged to usually improve after the SVR. We prospectively evaluated, in the PITER cohort, the long-term HCC risk profile based on predictors monitored after HCV eradication by direct-acting antivirals in patients with cirrhosis. Methods: HCC occurrence was evaluated by Kaplan-Meier analysis. Cox regression analysis identified the post-treatment variables associated with de-novo HCC; their predictive power was presented in a nomogram. Results: After the end of therapy (median follow-up:28.47 months), among 2064 SVR patients, 119 (5.8%) developed de-novo HCC. The HCC incidence was 1.90%, 4.21%, 6.47% at 12-, 24- and 36-months from end-of-therapy, respectively (incidence rate 2.45/100 person-years). Age, genotype 3, diabetes, platelets (PLT)≤120,000/µl and albumin ≤3.5g/dl levels were identified as pre-treatment HCC independent predictors. Adjusting for age, the post-treatment PLT≤120,000/µl (AdjHR 1.92; 95%CI:1.06-3.45) and albumin≤3.5g/dl (AdjHR 4.38; 95%CI 2.48-7.75) values were independently associated with HCC occurrence. Two different risk profiles were identified by combining long-term post-therapy evaluation of PLT ≤ vs. >120,000/µl and albumin ≤ vs. >3.5g/dl showing a significant different HCC incidence rate of 1.35 vs. 3.77/100 p-y, respectively. Conclusions: The nomogram score based on age, PLT and albumin levels after SVR showed an accurate prediction capability and may support the customizing management for early HCC detection.

Published
2023

47. BIO-RSA vs. metal-augmented baseplate in shoulder osteoarthritis with multiplanar glenoid deformity: a comparative study of radiographic findings and patient outcomes.

Author

Merolla, Giovanni, Giorgini, Andrea, Bonfatti, Rocco, Micheloni, Gian Mario, Negri, Alberto, Catani, Fabio, Tarallo, Luigi, Paladini, Paolo, and Porcellini, Giuseppe

Abstract

Reverse shoulder arthroplasty (RSA) requiring extensive reaming to address severe glenoid bone loss increases the risk of glenoid medialization and baseplate failure. We hypothesized that (1) metal-augmented baseplate prevents the medialization of the joint line and preserves glenoid bone stock similarly to bony increased-offset (BIO)-RSA and (2) bone graft viability and healing in BIO-RSA patients become compromised over time. Eighty-one patients (83 shoulders) underwent glenoid lateralization with bone (BIO-RSA group, 44) or metal-augmented baseplate (metallic increased-offset [MIO]-RSA group, 39) and a minimum follow-up of 24 months were included. The orientation and direction of glenoid erosion was identified and recorded using computerized 3D planning. Active range of motion, and the Western Ontario Osteoarthritis of the Shoulder (WOOS) index were assessed before arthroplasty and at the last follow-up visits. Radiographic changes around the glenoid and humeral components were assessed. Healing and thickness of bone graft were evaluated by predefined criteria. Postoperative global glenoid inclination (β angle) and retroversion were also measured. Delta scores of active anterior elevation were higher in the MIO-RSA group (P =.027). The differences in the other planes of shoulder motion and in WOOS index scores between the groups were not significant. Preoperative glenoid retroversion was higher in BIO-RSA patients, and glenoid inclination was similar in both groups. Type B2 and B3 glenoids had a posterior-central (91%) and posterior-superior (90%) erosion with a mean posterior humeral head subluxation of 76% and 78%, respectively. The direction of erosion in type E2 and E3 glenoids was posterior-superior, with a mean posterior humeral head subluxation of 74%. The rate of high position of the glenosphere was higher in the BIO-RSA group (P =.022), whereas the values of β angle and postoperative retroversion were similar in the 2 groups. BIO-RSA group showed radiolucent lines <2 mm around the bone graft in 16 patients (36.4%) and decreased thickness in 15 (34.1%). Incomplete baseplate seating was found in 4 MIO-RSA patients (10%). We found higher rates of humerus condensation lines in MIO-RSA patients (P =.01) and higher rates of cortical thinning and tuberosity resorption in the BIO-RSA group (P =.027 and P =.004, respectively). Metal-augmented glenoid is a suitable alternative to BIO-RSA to preserve bone and prevent the medialization of the joint line in arthritic glenoid with multiplanar glenoid deformity. Bone and metal augmentation provided satisfactory clinical outcomes. Bone graft resorption in BIO-RSA patients raise concern about the risk of baseplate loosening and requires further long-term studies. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results